Skip to content

Clinical trials

Immunoglobulin Light-chain Amyloidosis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Country / region: France Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20052
20081
20091
20111
20151
20161
20171
20191
20204
20211
20221
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC4
Prothena Biosciences Ltd.3
Alexion Pharmaceuticals, Inc.2
European Myeloma Network B.V.2
European Society for Blood and Marrow Transplantation1
GCS Ramsay Santé pour l'Enseignement et la Recherche1
Intergroupe Francophone du Myelome1
Millennium Pharmaceuticals, Inc.1
Nantes University Hospital1
Oncopeptides AB1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis20
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Follicular5
Amyloidosis4
Blast Crisis4
Burkitt Lymphoma4
Hodgkin Disease4
Immunoblastic Lymphadenopathy4
Infections4
Intraocular Lymphoma4

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.